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1513 N-acetylcysteine prevents reactive oxygen species–mediated myocardial stress
in patients undergoing cardiac surgery: Results of a randomized, double-
blind, placebo-controlled clinical trial
Paschalis Tossios, MD, Wilhelm Bloch, MD, Astrid Huebner, M. Reza Raji, MD, Fotini Dodos,
MD, Oliver Klass, MD, Michael Suedkamp, MD, Stefan-Mario Kasper, MD, Martin Hellmich,
PhD, and Uwe Mehlhorn, MD, Cologne, Germany
We investigated the effect of the antioxidant and reactive oxygen species (ROS) scavenger N-
acetylcysteine (NAC) versus placebo in 40 patients undergoing coronary artery bypass grafting.
Left ventricular 8-iso-prostaglandin-F2 and nitrotyrosine formation as markers for ROS-
mediated myocardial stress were significantly lower in patients receiving NAC. Thus, ROS-
scavenging with NAC attenuates oxidative stress in hearts of patients subjected to
cardiopulmonary bypass and cardioplegia.
1521 Gene expression profile after cardiopulmonary bypass and cardioplegic
arrest
Marc Ruel, MD, MPH, Cesario Bianchi, MD, PhD, Tanveer A. Khan, MD, Shu Xu, PhD,
John R. Liddicoat, MD, Pierre Voisine, MD, Eugenio Araujo, PhD, Helen Lyon, MD,
Isaac S. Kohane, MD, PhD, Towia A. Libermann, PhD, and Frank W. Sellke, MD, Boston,
Mass
Microarray techniques were used to define the gene expression changes that occur in the heart
and peripheral skeletal muscle of patients undergoing cardiac surgery with cardiopulmonary
bypass.
1531 Changes in left anterior descending coronary artery flow profiles after
coronary artery bypass grafting examined by means of transthoracic
Doppler echocardiography
Masao Yoshitatsu, MD, Yuji Miyamoto, MD, Masataka Mitsuno, MD, Koichi Toda, MD,
Masato Yoshikawa, MD, Shinya Fukui, MD, Fumikazu Nomura, MD, Nobuaki Hirata, MD, and
Kenji Onishi, MD, Osaka, Hiroshima, and Hyogo, Japan
We investigated the left anterior descending coronary artery flow profiles after coronary artery
bypass grafting (CABG) using transthoracic Doppler echocardiography (TTDE). After
successful CABG, TTDE showed a significant increase in peak and mean systolic and diastolic
velocities, diastolic velocity time integral (VTI), total VTI, and diastolic-to-systolic VTI ratio.
1537 Transplantation of cryopreserved muscle cells in dilated cardiomyopathy:
Effects on left ventricular geometry and function
Nobuhisa Ohno, MD, Paul W. M. Fedak, MD, Richard D. Weisel, MD, Donald A. G. Mickle,
MD, Takeshiro Fujii, MD, and Ren-Ke Li, MD, PhD, Toronto, Ontario, Canada
This study in hamsters was designed to establish proof of the concept that transplantation of
cryopreserved peripheral muscle cells into cardiomyopathic hearts can restore left ventricular
structure and function. Cryopreservation of donor cells might facilitate a clinically applicable
and effective approach for ventricular restoration with cell-transplantation therapy for patients
with inherited dilated cardiomyopathy.
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1549 Pretreatment with phenoxybenzamine attenuates the radial artery’s
vasoconstrictor response to -adrenergic stimuli
Joel S. Corvera, MD, Cullen D. Morris, MD, Jason M. Budde, MD, Daniel A. Velez, MD,
John D. Puskas, MD, Omar M. Lattouf, MD, William A. Cooper, MD, Robert A. Guyton, MD,
and Jakob Vinten-Johansen, PhD, Atlanta, Ga
A brief pretreatment of the radial artery bypass conduit with 1000 mol/L phenoxybenzamine
completely attenuated the vasoconstrictor responses to norepinephrine and phenylephrine. A
solution containing papaverine/lidocaine alone did not block vasoconstriction to these -
adrenergic agonists. Performance of a radial artery fasciotomy neither increased the efficacy of
the vasodilators nor altered endothelial function.
Evolving Technology
(ET)
1555 Evaluation of a novel sutureless anastomotic connector: From endothelial
function to mid-term clinical and angiographic follow-up
Subodh Verma, MD, PhD, Paul W. M. Fedak, MD, Lawrence Ko, BSc, Robert J. Cusimano,
MD, MSc, Nancy A. Walton, BScN, John D. Parker, MD, and Terrence M. Yau, MD, MSc,
Toronto, Ontario, Canada
The St Jude Medical sutureless connector for proximal anastomoses did not impair human
saphenous vein graft endothelium-dependent and endothelium-independent vasorelaxation. In
patients in whom the connector was implanted, 100% of grafts were patent 6 to 12 months
postoperatively but 22% demonstrated non–flow-limiting stenoses at or near the connector.
1561 Combined use of off-pump techniques and a sutureless proximal aortic
anastomotic device reduces cerebral microemboli generation during
coronary artery bypass grafting
John E. Scarborough, MD, William White, MPH, Frantz E. Derilus, BS, Joseph P. Mathew,
MD, Mark F. Newman, MD, and Kevin P. Landolfo, MD, for The Neurologic Outcome
Research Group (NORG), Durham, NC
Coronary artery bypass grafting with a combination of off-pump techniques and a sutureless
proximal aortic anastomotic device significantly reduces cerebral microembolic counts when
compared with standard techniques with cardiopulmonary bypass and hand-sewn proximal
anastomoses.
1568 Magnetic vascular coupling for distal anastomosis in coronary artery bypass
grafting: A multicenter trial
Uwe Klima, MD, PhD, Volkmar Falk, MD, PhD, Michael Maringka, Steffen Bargenda, MD,
Steven Badack, Anton Moritz, MD, PhD, Friedrich Mohr, MD, PhD, Axel Haverich, MD, PhD,
and Gerhard Wimmer-Greinecker, MD, PhD, Hannover, Leipzig, and Frankfurt, Germany
We report the clinical and angiographic results of a multicenter trial in 32 patients who
underwent distal coronary artery revascularization utilizing a magnetic anastomotic coupling
device.
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1575 Facilitated endoscopic beating heart coronary artery bypass grafting using a
magnetic coupling device
Volkmar Falk, MD, PhD, Thomas Walther, MD, PhD, Hubert Stein, BSc, BME,
Stephan Jacobs, MD, Claudia Walther, MD, Ardawahn Rastan, MD,
Gerhard Wimmer-Greinecker, MD, PhD, and Friedrich W. Mohr, MD, PhD,
Frankfurt and Leipzig, Germany, and Sunnyvale, Calif
A closed chest beating heart coronary artery bypass graft procedure using a robotically guided
magnetic coupling device was evaluated. The device facilitates the performance of an




1580 Extrapleural regional versus systemic analgesia for relieving
postthoracotomy pain: A clinical study of bupivacaine compared with
metamizol
Mehmet Bilgin, MD, Yigit Akcali, MD, and Fahri Oguzkaya, MD, Kayseri, Turkey
Controlling pain after thoracotomy is important for patients’ comfort and the prevention of
possible complications during the postoperative period. The effects of a local anesthetic
delivered through a catheter inserted in the extrapleural region by a surgeon and an analgesic
agent given systematically on pain after thoracotomy were assessed.
1584 Histogram analysis of computed tomography numbers of clinical T1 N0 M0
lung adenocarcinoma, with special reference to lymph node metastasis and
tumor invasiveness
Hiroaki Nomori, MD, PhD, Takashi Ohtsuka, MD, Tsuguo Naruke, MD, PhD, and
Keiichi Suemasu, MD, PhD, Tokyo, Japan
Histograms of CT numbers were made for clinical T1 N0 M0 lung adenocarcinomas. The
histogram showed 3 patterns: 1 peak at a low CT number, 1 peak at a high CT number, and 2
peaks. The adenocarcinomas with 1 peak at a low CT number had significantly less lymph
node metastasis or tumor involvement of vessels or pleura.
1590 Benefit of postoperative adjuvant chemoradiotherapy in locoregionally
advanced esophageal carcinoma
Thomas W. Rice, MD, David J. Adelstein, MD, Mark A. Chidel, MD, Lisa A. Rybicki, MS,
Malcolm M. DeCamp, MD, Sudish C. Murthy, MD, PhD, and Eugene H. Blackstone, MD,
Cleveland, Ohio
In patients with locoregionally advanced esophageal carcinoma, addition of postoperative
adjuvant chemoradiotherapy to esophagectomy alone doubled survival time, time to recurrence,
and recurrence-free survival. Patients found with locoregionally advanced carcinoma after
esophagectomy should be considered for adjuvant therapy.
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1597 Resection of multifocal non–small cell lung cancer when the
bronchioloalveolar subtype is involved
Peter F. Roberts, MD, Michaela Straznicka, MD, Primo N. Lara, MD, Derrick H. Lau, MD,
David M. Follette, MD, David R. Gandara, MD, and John R. Benfield, MD, Sacramento, Calif
The current staging system is not prognostic for N0 multifocal NSCLC, especially
bronchioloalveolar carcinoma. The 5-year survival for complete unilateral or bilateral resection
of such tumors was 64% in our study. We recommend resection of N0 multifocal disease when
bronchioloalveolar carcinoma is a component.
1603 Preoperative chemotherapy for esophageal cancer with paclitaxel and
carboplatin: Results of a phase II trial
R. S. Keresztes, MD, J. L. Port, MD, M. W. Pasmantier, MD, R. J. Korst, MD, and
N. K. Altorki, MD, New York, NY
A phase II preoperative taxane-based chemotherapy trial was conducted in patients with locally
advanced esophageal cancer. Overall response rate, resectability rate, and 3-year survival were
61%, 77%, and 48%, respectively. Resected patients had a 3-year survival of 64%.
1609 Cisplatin augments cytotoxic T-lymphocyte–mediated antitumor immunity in
poorly immunogenic murine lung cancer
Robert E. Merritt, MD, Ali Mahtabifard, MD, Reiko E. Yamada, BA, Ronald G. Crystal, MD,
and Robert J. Korst, MD, New York, NY
Systemically administered cisplatin enhances the antitumor effect and cure rate of an active
immunotherapy strategy in a poorly immunogenic, syngeneic, murine lung carcinoma model.
This phenomenon is due to up-regulation of Fas receptor on target tumor cells by cisplatin,
resulting in enhanced tumor cell lysis induced by cytotoxic T lymphocytes.
1618 Efficacy and safety of single-trocar technique for minimally invasive surgery
of the chest in the treatment of noncomplex pleural disease
Marcello Migliore, MD, PhD, FETCS, Catania, Italy
The goal of this study was to assess the results and the safety of minimally invasive surgery of
the chest through a single trocar in the management of noncomplex diseases. The technique is
simple, effective, and beneficial for all patients and opens the possibility to carry out simple




1624 Prolonged donor ischemic time does not adversely affect long-term survival
in adult patients undergoing cardiac transplantation
Jeffrey A. Morgan, MD, Ranjit John, MD, Alan D. Weinberg, MS, Aftab R. Kherani, MD,
Nicholas J. Colletti, BS, Deon W. Vigilance, MD, Faisal H. Cheema, MD,
Gianluigi Bisleri, MD, Thomas Cosola, PA, Donna M. Mancini, MD, Mehmet C. Oz, MD,
and Niloo M. Edwards, MD, New York, NY
Over the last 11 years, 819 adults underwent cardiac transplantation. Prolonged DIT (250
minutes) did not adversely affect survival, with 1-, 5-, and 10-year actuarial survival of 86.7%,
70.1%, and 50.9%. Procurement of hearts with prolonged DIT is justified in the setting of an
increasing recipient pool with a fixed donor population.
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Brief Communications 1634 Implantation of a left ventricular assist device and the hub-and-spoke system
in treating acute cardiogenic shock: Who survives?
Aftab R. Kherani, MD, Faisal H. Cheema, MD, Mehmet C. Oz, MD, Jennifer M. Fal, BA,
Jeffrey A. Morgan, MD, Veli K. Topkara, David A. Wilson, BA, Deon W. Vigilance, MD,
Mauricio J. Garrido, MD, and Yoshifumi Naka, MD, PhD, New York, NY
1636 Resistance to aspirin after external ventricular assist device implantation
Re´mi Houe¨l, MD, Elisabeth Mazoyer, MD, Matthias Kirsch, MD, PhD, Bernadette Boval, MD,
Ludovic Drouet, MD, PhD, and Daniel Y. Loisance, MD, Cre´teil and Paris, France
1638 Doppler microembolic signals during cardiac surgery: Comparison between
arterial line and middle cerebral artery
Dimitrios Georgiadis, MD, Antonia Hempel, Ralf W. Baumgartner, MD, and Hans-Reinhard
Zerkowski, MD, Halle/Saale, Germany, and Zurich and Basel, Switzerland
1639 Should HIV-positive recipients undergo heart transplantation?
Gianluigi Bisleri, MD, Jeffrey A. Morgan, MD, Mario C. Deng, MD, Donna M. Mancini, MD,
and Mehmet C. Oz, MD, New York, NY
1641 Should lungs from donors with severe acute pulmonary embolism be
accepted for transplantation? The Hannover experience
Stefan Fischer, MD, MSc, Bernhard Gohrbandt, MD, Anna Meyer, MD, Andre R. Simon, MD,
Axel Haverich, MD, PhD, and Martin Stru¨ber, MD, PhD, Hannover, Germany
1643 Isolated persistent fifth aortic arch with systemic-to-pulmonary arterial
connection
Mao-Sheng Hwang, MD, Yu-Sheng Chang, MD, Jaw-Ji Chu, MD, and Wen-Jen Su, MD,
Taoyuan, Taiwan
1645 Anomalous origin of the left coronary artery from the main pulmonary
artery associated with Berry syndrome
Hideaki Senzaki, MD, Haruhiko Asano, MD, Satoshi Masutani, MD, Tamotu Matunaga, MD,
Hirotaka Ishido, MD, Mio Taketatu, MD, Toshiki Kobayashi, MD, Nozomu Sasaki, MD,
Shunei Kyo, MD, and Yuji Yokote, MD, Saitama, Japan
1648 Successful Fontan procedure for asplenia with pulmonary atresia and major
aortopulmonary collateral arteries
Kagami Miyaji, MD, Nobuhiro Nagata, MD, Hikoro Matsui, MD, Takashi Miyamoto, MD, and
Kazuo Kitahori, MD, Yokohama, Japan
1650 Closed correction of systemic semilunar valve insufficiency in the neonate
Frank A. Pigula, MD, C. Becket Mahnke, MD, Petros Agnastopolous, MD, Alfonso Casta, MD,
Ricardo Munoz, MD, and Sanjiv K. Gandhi, MD, Pittsburgh, Pa
1653 Aortic arch repair with a working beating heart in premature infants
Kozo Ishino, MD, and Shunji Sano, MD, Okayama, Japan
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1655 Unroofed coronary sinus syndrome: Diagnosis, classification, and surgical
treatment
Yoshio Ootaki, MD, PhD, Masahiro Yamaguchi, MD, PhD, Naoki Yoshimura, MD, PhD,
Shigeteru Oka, MD, PhD, Masahiro Yoshida, MD, and Tomomi Hasegawa, MD, Kobe, Japan
1657 Single-finger subcutaneous defibrillation lead and “active can”: A novel
minimally invasive defibrillation configuration for implantable cardioverter-
defibrillator implantation in a young child
Nandini Madan, MD, J. William Gaynor, MD, Ronn Tanel, MD, Mitchell Cohen, MD,
Susan Nicholson, MD, Victoria Vetter, MD, and Larry Rhodes, MD, Philadelphia, Pa
Letters to the Editor 1660 Study design in valve surgery and outcome
Jeffrey H. Shuhaiber, MD, Malek Massad, MD, and Alexander Geha, MD, Chicago, Ill
1661 Reply
Gary L. Grunkemeier, PhD, and YingXing Wu, MD, Portland, Ore
1661 Esophageal perforation during left atrial radiofrequency ablation: Is the risk
too high?
A. Marc Gillinov, MD, Patrick M. McCarthy, MD, Gosta Pettersson, MD, Bruce W. Lytle, MD,
and Thomas W. Rice, MD, Cleveland, Ohio
1662 Reply
Nicolas Doll, MD, Michael A. Borger, MD, PhD, and Friedrich W. Mohr, MD, PhD, Leipzig,
Germany, and Toronto, Ontario, Canada
1662 Atrioesophageal fistula: Is it an unavoidable complication of radiofrequency
ablation?
Bingur Sonmez, MD, Ergun Demirsoy, MD, and Oguz Yilmaz, MD, Istanbul, Turkey
1663 Reply
Nicolas Doll, MD, Michael A. Borger, MD, PhD, and Friedrich W. Mohr, MD, PhD, Leipzig,
Germany, and Toronto, Ontario, Canada
1663 Authors should list confounding factors and alternative explanations for
adverse events seen with new technologies
Ani C. Anyanwu, FRCS, Middlesex, United Kingdom
1664 Reply
Lech Hornik, MD, PhD, Bad Oeynhausen, Germany
1664 Pattern of lymphatic spread and prognosis in pN1 non–small cell lung
cancer: What does it stand for?
Stefano Margaritora, MD, Alfredo Cesario, MD, and Pierluigi Granone, MD, Rome, Italy
1665 Reply
Alessandro Marra, MD, and Georgios Stamatis, MD, Essen, Germany
1666 Influence of chromosome 22q11.2 microdeletion on surgical outcome after
treatment of tetralogy of Fallot with pulmonary atresia
Adriano Carotti, MD, Bruno Marino, MD, and Roberto M. Di Donato, MD, Rome, Italy
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1667 Caveat against the use of FEIBA in combination with recombinant factor
VIIa
Christian von Heymann, MD, Sabine Ziemer, MD, Wolfgang J. Kox, MD, PhD, FRCP, and
Claudia Spies, MD, Berlin, Germany
1668 Is there an evidence in favor of off-pump coronary artery bypass?
Reida Menshawe El Oakley, MD, FRCS, Oon Cheong Ooi, AFRCS, and
Chuen Neng Lee, FRCS, Singapore, Singapore
1668 Short esophagi and a long career
Fernando Augusto Mardiros Herbella, MD, Sa˜o Paulo, Brazil
1668 Problems with complication rate analysis
D. Horstkotte, MD, Bad Oeynhausen, Germany
1670 Reply
YingXing Wu, MD, and Gary Grunkemeier, PhD, Portland, Ore
1670 Safety of bronchoplastic resection after induction therapy for lung cancer
G. Veronesi, MD, M. E. Leon, and L. Spaggiari, MD, PhD, Milan, Italy
1671 Reply
Mitsunori Ohta, MD, Noriyoshi Sawabata, MD, Hajime Maeda, MD, and Hikaru Matsuda,
MD, Osaka, Japan
1671 Lack of evidence for vitamin C as acute vasodilator
Anil Madhavan, FRCS, and Jonathan Goodfellow, FRCP, Cardiff, United Kingdom
1672 Reply
Ioannis K. Toumpoulis, MD, Constantine E. Anagnostopoulos, MD, and
George E. Drossos, MD, Ioannina, Greece
1673 Exhaled nitric oxide and cardiac surgery with extracorporeal circulation
Nandor Marczin, MD, PhD, Harefield, United Kingdom
1674 Reply
Ian Adatia, MBChB, Tilman Humpl, MD, and Philip E. Silkoff, MD, Toronto, Ontario, Canada,
and Denver, Colo
Events of Interest 1676 Events
Announcements The American Association for Thoracic Surgery
1678 Announcement of 2004 Annual Meeting
The Western Thoracic Surgical Association
1679 Announcement of 2004 Annual Meeting
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The American Board of Thoracic Surgery
1679 Notices
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Notices of Correction 1680 Correction of article by Costas Bizekis, MD, Giuseppe Pintucci, PhD,
Christopher C. Derivaux, MD, Fiorella Saponara, BA, Jin-Hee Kim, BS,
Kevin M. Hyman, MD, Eugene A. Grossi, MD, F. Gregory Baumann, PhD,
Paolo Mignatti, MD, and Aubrey C. Galloway, MD, titled “Activation of
mitogen-activated protein kinases during preparation of vein grafts and
modulation by a synthetic inhibitor” (2003;126:659-65)
1680 Correction of article by Marjan Jahangiri, FRCS, James Clark, FRCA,
Fredrico Prefumo, MD, Charles Pumphrey, FRCP, and David Ward, FRCP,
titled “Cardiac surgery during pregnancy: Pulsatile or nonpulsatile perfusion?”
(2003;126:894-5)
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